A detailed history of Capitolis Liquid Global Markets LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 235,000 shares of BSX stock, worth $24.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
235,000
Previous 160,000 46.88%
Holding current value
$24.1 Million
Previous $17.2 Billion 99.87%
% of portfolio
0.19%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$97.03 - $108.14 $7.28 Million - $8.11 Million
75,000 Added 46.88%
235,000 $22.9 Million
Q2 2025

Aug 14, 2025

BUY
$89.7 - $107.41 $14.4 Million - $17.2 Million
160,000 New
160,000 $17.2 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Capitolis Liquid Global Markets LLC Portfolio

Follow Capitolis Liquid Global Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Liquid Global Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Liquid Global Markets LLC with notifications on news.